FIM
COLL icon

Freedom Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Freedom Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,515
Closed -$214K – 793
2024
Q1 		$214K Buy
+5,515
New +$193K 0.02% 723
2021
Q2 		– Sell
-8,942
Closed -$212K – 878
2021
Q1 		$212K Buy
+8,942
New +$212K 0.02% 778

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Freedom Investment Management's COLL Position: Q2 2024 in Review

Freedom Investment Management sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 5,515 shares — an estimated $214K sold.

Freedom Investment Management first reported a position in COLL in Q1 2021 and held it in 2 quarters. The position peaked at $214K in Q1 2024. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

  • Freedom Investment Management reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Freedom Investment Management sold 5,515 Collegium Pharmaceutical shares in Q2 2024, an estimated $214K.
  • Freedom Investment Management first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 2 quarters.
  • Freedom Investment Management's Collegium Pharmaceutical position peaked at $214K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Freedom Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.